Affiliation:
1. Central Laboratory of Panyu Central Hospital, Guangzhou Panyu Central Hospital, Guangzhou, Guangdong 511400, China
2. Laboratory Department of Panyu Central Hospital, Guangzhou, Guangdong 511400, China
Abstract
Objective. To determine the effects of circSPECC1 (hsa_circ_0000745) on the proliferation and migration of LNCaP prostate cancer cells and to explore the potential molecular mechanism. Methods. Stable circSPECC1 shRNA-expressing and circSPECC1-overexpressing LNCaP cell lines were constructed, and relative gene expression levels were determined by RT-PCR. MTT and clonogenic assays were used to assess proliferative ability while a scratch test was used to analyze cell migration. Western blotting was used to determine protein expression levels. The effects of circSPECC1 on the proliferation of LNCaP prostate cancer cells were observed in vivo. Results. circSPECC1 was found to be derived from the SPECC1 (sperm antigen with calponin homology and coiled-coil domains 1) parent gene and to form a loop. Overexpression of circSPECC1 promoted the proliferation and migration of the LNCaP cells, whereas decreased expression of circSPECC1 inhibited these properties. Overexpression of circSPECC1 promoted the expression of MMP-2, MMP-9, VEGF, vimentin, and N-cad but downregulated the expression of E-cad. Decreased expression of circSPECC1 inhibited the expression of MMP-2, MMP-9, VEGF, vimentin, and N-cad but increased the expression of E-cad. Conclusion. circSPECC1 promotes cell proliferation and migration by affecting the epithelial-mesenchymal transition of LNCaP prostate cancer cells.
Funder
Scientific Research Fund Project of Guangzhou Panyu Central Hospital
Subject
Immunology,General Medicine,Immunology and Allergy
Reference19 articles.
1. circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy
2. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
3. Chinese expert consensus on surgical treatment of prostate cancer;Minimally invasive group, urogenital tumor professional committee, Chinese anti-cancer association;Zhejiang Medical Journal,2018
4. Survival follow-up data analysis of prostate cancer patients;L. Xiaosheng;Chinese Medical Record,2019
5. Diagnosis, treatment and prognosis of 1673 cases of prostate cancer: a 10-year retrospective analysis of a single center in Shanghai;L. Xu;Journal of Fudan Medical Sciences,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献